AlphaYouAB
Insider buying
Andrew Booth bought $384K of AbCellera Biologics Inc. (ABCL) stock
Andrew Booth, Chief Financial Officer of AbCellera Biologics Inc. (ABCL), bought 37,200 shares of ABCL stock worth $384K, per an SEC Form 4 filed Aug 14, 2026.
It was an open-market purchase.
The trade was reported on Aug 14, 2026.
ABCL has moved +11.2% since the trade date, from $11.38 to $12.66 (Sep 21, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 14, 2026
- Filing delay
- 0 days
- Price since
- +11.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More ABCL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.